Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer: A single institution phase II study

Lung Cancer

Volumn 47, Issue 2, 2005, Pages 269-275

  Dongiovanni, Diego ^a   Fissore, Camilla ^a   Berruti, Alfredo ^b   Buffoni, Lucio ^a   Addeo, Alfredo ^a   Barone, Carla ^a   Polimeni, Maria Antonia ^a   Ottaviani, Davide ^a   Bertetto, Oscar ^a   Dongiovanni, Vincenzo ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Cisplatin; Gemcitabine; Non small cell lung cancer; Paclitaxel; Sequential chemotherapy; Vinorelbine

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ALLERGIC REACTION; ALOPECIA; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUTROPENIA; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 19944427357     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.06.019     Document Type: Article

References (26)

1. A. Verdecchia Survival in adult patients, 1978-1989 ITACARE Working group Tumori 83 1997 39 425
2. Non-Small-Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995; 311: 99-909.
3. M.H. Cullen, L.J. Billingham, and C.M. Woodroffe Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life J. Clin. Oncol. 17 1999 3188 3194
4. J.H. Schiller, D. Harrington, and C.P. Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N. Engl. J. Med. 346 2002 92 98
5. R. Rosell, U. Gatzmeier, and D.C. Betticher Phase III randomized trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial Ann. Oncol. 13 2002 1539 1549
6. P. Bonomi, K.M. Kim, and D. Fairclough Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial J. Clin. Oncol. 18 2000 623 631
7. T. Le Chevalier, D. Brisgand, and J.Y. Douillard Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients J. Clin Oncol. 12 1994 360 367
8. U. Gatzemeier, J. von Pawel, and M. Gottfried Phase III comparative study of high-dose cisplatin vs. a combination of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer J. Clin. Oncol. 18 2000 3390 3399
9. A.J. Wozniak, J.J. Crowley, and S.P. Balcerzac Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group Study J. Clin. Oncol. 16 1998 2459 2465
10. N. Murray The importance of drug diversity in the treatment of small cell lung cancer Semin Oncol. 28 Suppl. 4 2001 S38 S42
11. P. Perego, M. Giarola, and S.C. Righetti Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems Cancer Res. 56 1996 556 562
12. D. Gandara, E. Vokes, and M. Green Activity of docetaxel in platinum-treated non-small cell lung cancer: results of a Phase II multicentric trial J. Clin. Oncol. 18 2000 131 135
13. F. Sheperd, J. Dancey, and R. Ramlau Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy J. Clin. Oncol. 18 2000 2095 2103
14. P. Kosmidis, N. Mylonakis, and C. Nicolaides Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial J. Clin. Oncol. 20 2002 3578 3585
15. E.F. Smith, and J.P. Van Meerbeek Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975 J. Clin. Oncol. 21 2003 3909 3917
16. A.B. Miller, B. Hoogstraten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
17. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10
18. R.S. Day Treatment sequencing, asymmetry and uncertainty: protocol strategies for combination chemotherapy Cancer Res. 46 1996 3876 3885
19. L. Norton, and R. Simon The Norton-Simon hypothesis revisited Cancer Treat. Res. 70 1986 163 169
20. I. Smith, M. O'Brien, and T. Talbot Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine and cisplatin J. Clin. Oncol. 19 2001 1336 1343
21. M. Socinski, M. Schell, and A. Peterman Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced stage IIIB/IV non-small-cell lung cancer J. Clin. Oncol. 20 2002 1335 1342
22. L.E. Gaspar, C. Scott, and K. Murray Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases Int. J. Radiat. Oncol. Biol. Phys. 47 2000 1001 1006
23. G. Bernardo, Q. Cuzzoni, and M.R. Strada First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study Cancer Invest. 20 2002 293 302
24. M.J. Edelman, D.R. Gandara, and D.H. Lau Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel Cancer 92 2001 146 152
25. J.I. Clark, K. Kancharla, and R. Qamar Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer Lung Cancer 34 2001 271 277
26. J. Feliu, G. Martin, and J. Lizon Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine: a phase II study Ann Oncol. 12 2001 1369 1374